单位：[1]Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.[2]Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, P. R. China.[3]Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, P. R. China.[4]Department of Radiation Oncology, Zhejiang Cancer Hospital, Zhejiang Province Key Laboratory of Radiation Oncology, Hangzhou, P. R. China.浙江省肿瘤医院[5]Department of Neurosurgery, Third Affiliated Hospital of Southern Medical University, Guangzhou, P. R. China.[6]Department of Surgery, LKS Faculty of Medicine, The University of Hong, Hong Kong, P. R. China.[7]Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, P. R. China.首都医科大学附属北京同仁医院首都医科大学附属同仁医院[8]Key Laboratory of Otolaryngology Head and Neck Surgery, Ministry of Education, Beijing, P. R. China.首都医科大学附属同仁医院[9]Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, P. R. China.[10]Department of Radiation Oncology, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, P. R. China.[11]Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P. R. China.[12]Department of Oncology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, P. R. China.肿瘤科华中科技大学同济医学院附属同济医院[13]Department of Otolaryngology Head and Neck Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, P. R. China.[14]Department of Otolaryngology Head and Neck Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China.[15]Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, P. R. China.[16]Department of Radiation Oncology, Jiangxi Cancer Hospital of Nanchang University, Nanchang, Jiangxi, P. R. China.[17]Department of Radiation Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, P. R. China.[18]Department of Otorhinolaryngology Head and Neck Surgery, the Second Affiliated Hospital of Nanchang University, Nanchang, P. R. China.[19]Department of Otorhinolaryngology, Shenzhen Second People's Hospital/The First Affiliated Hospital of Shenzhen University, Shenzhen, P. R. China.深圳市第二人民医院深圳市康宁医院深圳医学信息中心[20]Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, P. R. China.[21]Department of Otorhinolaryngology, Centro Hospitalar C.S. Januario Macau, Macau, P. R. China.[22]Department of Otorhinolaryngology-Head and Neck Surgery, The First Affiliated Hospital, University of Science and Technology of China, Hefei, P. R. China.[23]ENT Institute and Department of Otorhinolaryngology, Eye and ENT Hospital, Fudan University, Shanghai, P. R. China.[24]Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, P. R. China.[25]Department of Radiation Oncology, The Affiliated Tumor Hospital of Guangxi Medical University, Guangxi, P.R. China.[26]Department of Otolaryngology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.中山大学附属第一医院
Surgical treatment is playing an increasingly important role in the management of nasopharyngeal carcinoma (NPC). This consensus focuses on the indications for optimal surgery, and surgical methods in the whole process of treatment for NPC to provide a useful reference to assist these difficult clinical decisions.A thorough review of available literature on NPC and surgery was conducted by the Association for the prevention and treatment of nasopharyngeal carcinoma in China, international exchange and promotion Association for medicine and healthcare, and the Committee on nasopharyngeal cancer of Guangdong provincial anticancer association. A set of questions and a preliminary draft guideline was circulated to a panel of 1096 experienced specialists on this disease for voting on controversial areas and comments. A refined second proposal, based on a summary of the initial voting and different opinions expressed, was recirculated to the experts in two authoritative medical science and technology academic groups in the prevention and treatment of NPC in China for review and reconsideration.The initial round of questions showed variations in clinical practice even among similar specialists, reflecting the lack of high-quality supporting data and resulting difficulties in formulating clinical decisions. Through exchange of comments and iterative revisions, recommendations with high-to-moderate agreement were formulated on general treatment strategies and details of surgery, including indications and surgical approaches.By standardizing the surgical indications and practice, we hope not only to improve the surgical outcomes, but also to highlight the key directions of future clinical research in the surgical management of NPC.
第一作者单位：[1]Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.[2]Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, P. R. China.[3]Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, P. R. China.
通讯作者：
通讯机构：[1]Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.[2]Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, P. R. China.[3]Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, P. R. China.[7]Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, P. R. China.[8]Key Laboratory of Otolaryngology Head and Neck Surgery, Ministry of Education, Beijing, P. R. China.[26]Department of Otolaryngology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.[*1]Department of Nasopharyngeal Carcinoma Sun Yat-sen University Cancer Center 651 Dongfeng East Road Guangzhou Guangdong 510060 P. R. China[*2]Department of Otolaryngology the First Affiliated Hospital of Sun Yat-sen University Guangzhou P.R. China[*3]Department of Otolaryngology Head and Neck Surgery Beijing Tongren Hospital Capital Medical University Beijing, P. R. China. Key Laboratory of Otolaryngology Head and Neck Surgery Ministry of Education Beijing P. R. China
推荐引用方式(GB/T 7714)：
You R,Liu Y P,Chen X Z,et al.Surgical treatment of nasopharyngeal cancer - a consensus recommendation from three Chinese associations[J].RHINOLOGY.2024,62(1):doi:10.4193/Rhin23.054.
APA：
You R,Liu Y P,Chen X Z,Chen J H,Chan J Y W...&Han D M.(2024).Surgical treatment of nasopharyngeal cancer - a consensus recommendation from three Chinese associations.RHINOLOGY,62,(1)
MLA：
You R,et al."Surgical treatment of nasopharyngeal cancer - a consensus recommendation from three Chinese associations".RHINOLOGY 62..1(2024)
